🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Global Blood Therapeutics Inc (GBT)

NASDAQ
Currency in USD
Disclaimer
68.49
0.00(0.00%)
Closed
Fair Value
Day's Range
68.4768.49
52 wk Range
21.6573.02
Prev. Close
68.49
Open
68.48
Day's Range
68.47-68.49
52 wk Range
21.65-73.02
Volume
0
Average Volume (3m)
3,824,945
1-Year Change
0%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
GBT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Global Blood Therapeutics Inc Company Profile

Global Blood Therapeutics, Inc., a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat grievous blood-based disorders. The company offers Oxbryta tablets, an oral once-daily therapy for SCD. It also evaluates pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company develops its lead product candidate inclacumab, a human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises and resulting hospital admissions and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. Global Blood Therapeutics, Inc. was incorporated in 2011 and is based in South San Francisco, California with additional locations in Baar, Switzerland; Paris, France; Berlin, Germany; and London, United Kingdom. As of October 5, 2022, Global Blood Therapeutics, Inc. operates as a subsidiary of Pfizer Inc.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.